Free fatty acids impair hepatic insulin extraction in vivo

Diabetes

Volumn 48, Issue 4, 1999, Pages 766-774

  Wiesenthal, Stephanie R ^a   Sandhu, Harmanjit ^a   McCall, Richard H ^a   Tchipashvili, Vaja ^a   Yoshii, Hidenori ^a   Polonsky, Kenneth ^c   Shi, Zed Q ^a   Lewis, Gary F ^a   Mari, Andrea ^b   Giacca, Adria ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b CNR   (Italy)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCAGON; GLYCEROL; INSULIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; GLUCAGON BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HYPERINSULINEMIA; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN INFUSION; INSULIN METABOLISM; INSULIN RELEASE; INSULINEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032999369     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.4.766     Document Type: Article

References (60)

1. Despres JP, Lamarche B, Mauriege P: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
2. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E: Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435-441, 1988
3. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH: Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest 78:1648-1657, 1986
4. Rossell R, Gomis R, Casamitjana R, Segura R, Vilardell E, Rivera F: Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J Clin Endocrinol Metab 56:608-611, 1983
5. Faber OK, Christensen K, Kehlet H, Madsbad S, Binder C: Decreased insulin removal contributes to hyperinsulinemia in obesity. J. Clin Endocrinol Metab 53:618-621, 1981
6. Stromblad G, Bjorntorp P: Reduced hapatic insulin clearance in rats with dietary-induced obesity. Metabolism 35:323-327, 1986
7. Karakash C, Assimacopoulos-Jeannet F, Jeanrenaud B: An anomaly of insulin removal in perfused livers of obese-hyperglycemic (ob/ob) mice. J Clin Invest 57:1117-1124, 1976
8. Gorden ES: Non-esterified fatty acids in blood of obese and loan subjects. Am J Clin Nutr 8:740-747, 1960
9. Reaven GM, Hollenbeck C, Jeng C-Y, Wu MS, Chen Y-D: Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 h in patients with NIDDM. Diabetes 3720: 1020-1024, 1988
10. Reaven G: Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486, 1995
11. Svederg J, Bjorntorp P, Smith U, Lonnroth P: Free fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39:570-574, 1990
12. Hennes MMI, Shrago E, Kissebah AH: Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obesity 14:831-841, 1990
13. Svedberg J, Bjorntorp P, Smith U, Lonnroth P: Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and obese rats. Diabetes 41:294-298, 1992
14. Hennes MMI, Shrago E, Kissebah AH: Mechanism of free fatty acid effects on hepatocyte insulin receptor binding and processing. Obesity Res 1:18-28, 1993
15. Svedberg J, Stromblad G, Wirth A, Smith U, Bjorntorp P: Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J. Clin Invest 88:2054-2058, 1991
16. Matsuhisa M, Shi ZQ, Wan C, Lekas M, Rodgers CD, Giacca A, Kawamori R, Vranic M: The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs. Diabetes 46:224-231, 1987
17. Bezman-Tarcher A: Method for continuous intravenous infusion of large amounts of oleic acid into rats. J Lipid Res 10:197-206, 1969
18. Felber JP: Insulin secretion. In From Obesity to Diabetes. Felber JP, Acheson KJ, Tappy L. Eds. Chichester, U.K., Wiley, 1993, p. 33-44
19. Lookene A, Skottova N, Olivecrona G: Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipostatin (Orlistat). Eur J Biochem 222:395-403, 1994
20. Borgstrom B: Mode of action of tetrahydrolipostatin: a derivative of the naturally occurring lipase inhibitor lipostatin. Biochim Biophys Acta 962:308-316, 1988
21. Miles J, Glasscock R, Aikens J, Gerich J, Haymond M: A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24:96-99, 1983
22. Polonsky K, Jaspan J, Pugh W, Cohen D, Schneider M, Schwartz T, Moossa AR, Tager H, Rubenstein AH: Metabolism of C-peptide in the dog. J Clin Invest 72:1114-1123, 1983
23. Lloyd B, Burrin J, Smythe P, Alberti KGMM: Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 24:1724-1729, 1978
24. Mari A: Circulatory models of intact-body kinetics and their relationships with compartmental and non-compartmental analysis. J Theor Biol 160:509-531, 1993
25. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
26. Myers SR, Biggers DW, Neal DW, Cherrington AD: Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo. J Clin Invest 88:158-167, 1991
27. Ader M, Bergman RN: Peripheral effects of insulin dominate suppression of fasting hepatic-glucose production. Am J Physiol 245:E1020-E1032, 1990
28. Mari A: Estimation of the rate of appearance in the non-steady state with a two-compartmental model. Am J Physiol 263:E400-E415, 1992
29. Dobbins RL, Davis SN, Neal DW, Cobelli C, Jaspan J, Cherrington AD: Compartmental modeling of glucagon kinetics in the conscious dog. Metabolism 44:452-450, 1995
30. Kral JG, Lundholm K, Bjorntorp P, Sjostrom P, Schersten T: Hepatic lipid metabolism in severe human obesity. Metabolism 26:1025-1031, 1977
31. Goto T, Onuma T, Takebe K, Kral JG: The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes 19:841-845, 1995
32. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG: Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes 19:846-850, 1995
33. Saloranta C, Koivisto V, Widen E, Falholt K, DeFronzo R, Harkonen M, Groop L: Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 264:E599-E605, 1993
34. Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, Ferrannini E: Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 36:502-506, 1987
35. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
36. Hennes MMI, Dua A, Kissebah AH: Effect of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46:57-62, 1997
37. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86, 1985
38. Stevenson RW, Cherrington AD, Steiner KE: The relationship between plasma concentration and disappearance rate of immunoreactive insulin in the conscious dog. Horm Metab Res 17:551-553, 1985
39. Ferrannini E, Cobelli C: The kinetics of insulin in man: I. General aspects. Diabetes Metab Rev 3:335-363, 1987
40. Morishima T, Pye S, Bradshaw C, Radziuk J: Posthepatic rate of appearance of insulin: measurement and validation in the nonsteady state. Am J Physiol 263:E772-E779, 1992
41. Morishima T, Bradshaw C, Radziuk J: Measurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs. Am J Physiol 248:E203-E208, 1985
42. Pye S, Watarai T, Radziuk J: Comparison of the continuously calculated fractional splanchnic extraction of insulin with its fractional disappearance using a new double-tracer technique. Metabolism 42:145-153, 1993
43. Chamberlain MJ, Stimmler L: The renal handling of insulin. J Clin Invest 46:911-919, 1967
44. Rabkin R, Colwell JA: The renal uptake and excretion of insulin in the dog. J Lab Clin Med 73:893-900, 1969
45. Katz I, Rubenstein AH: Metabolism of proinsulin, insulin and C-peptide in the rat. J Clin Invest 52:1113-1121, 1973
46. Maude DL, Handelsman DG, Babu M, Gordon E: Handling of insulin by the isolated perfused rat kidney. Am J Physiol 2408:F288-F294, 1981
47. Ferrannini E, Wahren J, Faber O, Felig P, Binder C, DeFronzo R: Splanchnic and renal metabolism of insulin in human subjects: a dose response study. Am J Physiol 244:E517-E527, 1983
48. Polonsky K, Jaspan J, Emmanouel D, Holmes K, Moosa R: Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. Acta Eudocrinol (Copenh) 102:420-427, 1983
49. Svedberg J, Bjorntorp P, Lonnroth P, Smith U: Prevention of inhibitory effect of free fatty acids on insulin binding and action in isolated rat hepatocytes by etomoxir. Diabetes 40:783-786, 1991
50. Diaz-Guerra MJM, Junco M, Bosca L: Oleic acid promotes changes in the subcellular distribution of protein kinase C in isolated hepatocytes. J Biol Chem 266:23568-23576, 1991
51. Iacopetta BJ, Carpentier JL, Pozzan T, Lew DP, Gorden P, Orci L: Role of intracellular calcium and protein kinase C in the endocytosis of transferrin and insulin by HL60 cells. J Cell Biol 103:851-856, 1986
52. Grunberger G, Iacopetta B, Carpentier JL, Gorden P: Diacylglycerol modulation of insulin receptor from cultured human mononuclear cells. Diabetes 35:1364-1370, 1986
53. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
54. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C: Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88:960-966, 1991
55. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD: The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46:187-196, 1997
56. Rebrin K, Steil GM, Mittelman SD, Bergman RN: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
57. Herrera MG, Kamm D, Ruderman N, Cahill GF: Non-hormonal factors in the control of gluconeogenesis. Adv Enzyme Regul 4:225-235, 1966
58. McCall RH, Wiesenthal SR, Shi ZQ, Polonsky K, Giacca A: Insulin acutely suppresses glucose production by both peripheral and hepatic effect in normal dogs. Am J Physiol 274:E346-E356, 1998
59. Lewis GF, Vranic M, Harley P, Giacca A: Fatty acids mediate the acute extra-hepatic effects of insulin on hepatic glucose production in humans. Diabetes 46:1111-1119, 1997
60. Carpentier JL: The journey of the insulin receptor into the cell: from cellular biology to pathophysiology. Histochem 100:169-184, 1993